These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9353855)

  • 1. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group.
    White L; Harvey PD; Opler L; Lindenmayer JP
    Psychopathology; 1997; 30(5):263-74. PubMed ID: 9353855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the PANSS pentagonal and Van Der Gaag 5-factor models for assessing change over time.
    Jerrell JM; Hrisko S
    Psychiatry Res; 2013 May; 207(1-2):134-9. PubMed ID: 23313304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor structure and external validity of the PANSS revisited.
    Van den Oord EJ; Rujescu D; Robles JR; Giegling I; Birrell C; Bukszár J; Murrelle L; Möller HJ; Middleton L; Muglia P
    Schizophr Res; 2006 Feb; 82(2-3):213-23. PubMed ID: 16229988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients.
    Fresán A; De la Fuente-Sandoval C; Loyzaga C; García-Anaya M; Meyenberg N; Nicolini H; Apiquian R
    Schizophr Res; 2005 Jan; 72(2-3):123-9. PubMed ID: 15560957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia.
    Rodriguez-Jimenez R; Bagney A; Mezquita L; Martinez-Gras I; Sanchez-Morla EM; Mesa N; Ibañez MI; Diez-Martin J; Jimenez-Arriero MA; Lobo A; Santos JL; Palomo T;
    Schizophr Res; 2013 Jan; 143(1):77-83. PubMed ID: 23201306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANSS-6: a brief rating scale for the measurement of severity in schizophrenia.
    Østergaard SD; Lemming OM; Mors O; Correll CU; Bech P
    Acta Psychiatr Scand; 2016 Jun; 133(6):436-44. PubMed ID: 26558537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the factor structure of symptoms in patients with schizophrenia.
    Kim JH; Kim SY; Lee J; Oh KJ; Kim YB; Cho ZH
    Psychiatry Res; 2012 May; 197(3):285-9. PubMed ID: 22364933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
    Rekhi G; Alphs L; Ang MS; Lee J
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP; Brown E; Baker RW; Schuh LM; Shao L; Tohen M; Ahmed S; Stauffer VL
    Schizophr Res; 2004 Jun; 68(2-3):331-7. PubMed ID: 15099614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive, positive, negative and parkinsonian symptomsin schizophrenia.
    Fitzgerald PB; Rolfe TJ; Brewer K; Filia K; Collins J; Filia S; Adams A; de Castella A; Davey P; Kulkarni J
    Aust N Z J Psychiatry; 2002 Jun; 36(3):340-6. PubMed ID: 12060182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-national factor analytic comparison of three models of PANSS symptoms in schizophrenia.
    Stefanovics EA; Elkis H; Zhening L; Zhang XY; Rosenheck RA
    Psychiatry Res; 2014 Oct; 219(2):283-9. PubMed ID: 24930581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing positive and negative symptoms in children and adolescents.
    Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
    Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Davidson M; Saoud J; Staner C; Noel N; Luthringer E; Werner S; Reilly J; Schaffhauser JY; Rabinowitz J; Weiser M; Luthringer R
    Am J Psychiatry; 2017 Dec; 174(12):1195-1202. PubMed ID: 28750582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?
    Anderson A; Wilcox M; Savitz A; Chung H; Li Q; Salvadore G; Wang D; Nuamah I; Riese SP; Bilder RM
    Psychiatry Res; 2015 Feb; 225(3):283-90. PubMed ID: 25613662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A confirmatory factor analytic evaluation of the pentagonal PANSS model.
    Fitzgerald PB; de Castella AR; Brewer K; Filia K; Collins J; Davey P; Rolfe T; Kulkarni J
    Schizophr Res; 2003 May; 61(1):97-104. PubMed ID: 12648740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.